Quarter ended Sep 2026: consolidated revenue up 61% from year ago, but net loss Rs 721 lakh

Going-concern doubtEmphasis of matterNet loss reportedDebt to equity above the thresholdRevenue declinedEBITDA margin expansionResults View source PDF Explain this filing

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

—Next day

₹30.80

prior close

₹30.60

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used——

Pharmaceuticals peers, median of 173sector——

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.0

10m

-2.7

15m

+0.9

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

———-0.2—

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated quarter ended September 30, 2026: revenue from operations was Rs 7,939.24 lakh, up 61.2% from Rs 4,926.05 lakh a year earlier, and net loss was Rs 720.93 lakh versus Rs 724.62 lakh. Consolidated half-year: revenue Rs 13,651.17 lakh and net loss Rs 675.19 lakh. The auditor flagged non-performing bank debt, current liabilities above assets, a Rs 2,671.57 lakh demand notice and going-concern uncertainty, but gave an unmodified opinion.

Likely market impact

Revenue growth helps, but losses, non-performing bank debt and going-concern uncertainty create major downside risk for shareholders.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹79.39 Cr	₹106.9 Cr	−25.7%
Operating profit	−₹9.16 Cr	−₹25.49 Cr	loss narrowed
Profit after tax	−₹7.21 Cr	−₹21.14 Cr	loss narrowed
EBITDA margin	-1.4%	-6.8%	+5.4 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.